<DOC>
	<DOCNO>NCT01423474</DOCNO>
	<brief_summary>The purpose study compare toxicity two new radiation schedule treatment prostate cancer . Patients randomize receive 5 treatment deliver every day 11 day , per week 29 day . Both schedule short standard treatment usually 39 treatment 8 week .</brief_summary>
	<brief_title>Prostate Accurately Targeted Radiotherapy Investigation Overall Treatment Time</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Low intermediate risk prostate cancer patient define : Clinical stage T12b , Gleason Score &lt; =7 , PSA &lt; =20 ng/mL Age &gt; = 18 year Androgen deprivation therapy ( LHRHagonists antiandrogens ) &gt; 6 month Prior pelvic radiotherapy Anticoagulation medication ( unsafe discontinue gold seed insertion ) Diagnosis bleed diathesis Large prostate ( &gt; 90cm3 ) image Immunosuppressive medication Inflammatory bowel disease</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Radiotherapy</keyword>
	<keyword>Hypofractionation</keyword>
</DOC>